Drug For Coronavirus Could Be A Game Changer
Good news from a company called Gilead Sciences.
BEIJING, CHINA – JANUARY 26: A health worker checks the temperature of women entering the subway on January 26, 2020 in Beijing, China. The number of cases of coronavirus rose to 1,975 in mainland China on Sunday. Authorities tightened restrictions on travel and tourism this weekend after putting Wuhan, the capital of Hubei province, under quarantine on Thursday. The spread of the virus corresponds with the first days of the Spring Festival, which is one of the biggest domestic travel weeks of the year in China. Popular tourism landmarks in Beijing including the Forbidden City, Badaling Great Wall, and The Palace Museum were closed to the public starting Saturday. The Beijing Municipal Education Commission announced it will delay reopening schools from kindergarten to university. The death toll on Sunday rose to 56. The majority of fatalities are in Wuhan where the first cases of the virus were reported last month.(Photo by Betsy Joles/Getty Images)
Good news from a company called Gilead Sciences.
Gilead Sciences has a drug that is showing fantastic early results. It's called Remdesivir. It is having solid effectiveness in treating COVID-19 patients.
A recent clinical trial of the drug resulted in rapid recoveries in patients' fever and respiratory symptoms. Remdesivir is an antiviral medicine used as a potential treatment for Ebola.
The trial was conducted by the University of Chicago Medicine. It found nearly all patients who were given daily infusions of Remdesivir were discharged from the hospital in less than a week. Keep your fingers crossed, that this is the drug that could be a game-changer.
